Jason N Gorevic's Insider Trades & SAST Disclosures
Jason N Gorevic's most recent trade in Kemper Corporation was a trade of 2,435 Common Stock done at an average price of $61.6 . Disclosure was reported to the exchange on May 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jason N Gorevic.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kemper Corporation | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 61.61 per share. | 07 May 2025 | 2,435 | 20,072 (0%) | 0% | 61.6 | 150,020 | Common Stock |
| Kemper Corporation | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 2,565 | 17,637 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 197,728 | 197,728 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 63,393 | 63,393 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 62,004 | 124,008 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 62,004 | 699,180 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 14.52 per share. | 01 Mar 2024 | 53,755 | 653,073 (0%) | 0% | 14.5 | 780,308 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 21,130 | 42,263 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 21,130 | 622,864 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,648 | 706,828 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,648 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,782 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,782 | 631,561 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,615 | 22,460 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,615 | 637,176 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,915 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,915 | 625,779 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason Gorevic N. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 5,615 | 604,611 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Gorevic Jason N. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 5,615 | 28,075 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | N. Jason Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.90 per share. | 01 Dec 2023 | 2,877 | 601,734 (0%) | 0% | 18.9 | 54,381 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 5,614 | 601,860 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 5,614 | 33,690 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 22.89 per share. | 01 Sep 2023 | 2,864 | 598,996 (0%) | 0% | 22.9 | 65,568 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 27 Jul 2023 | 10,000 | 596,246 (0%) | 0% | 30.0 | 300,303 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 5,614 | 39,304 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 5,614 | 609,048 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 01 Jun 2023 | 2,802 | 606,246 (0%) | 0% | 24.4 | 68,316 | Common Stock |
| Kemper Corporation | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 2,933 | 15,072 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 186,012 | 186,012 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.91 per share. | 03 Mar 2023 | 22,040 | 603,434 (0%) | 0% | 25.9 | 571,078 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 22,458 | 588,922 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 22,458 | 44,918 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 15,476 | 605,240 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 15,476 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 9,104 | 589,764 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 9,104 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.36 per share. | 01 Mar 2023 | 8,262 | 580,660 (0%) | 0% | 25.4 | 209,541 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 7,648 | 616,779 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 7,648 | 7,648 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,828 | 5,828 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 5,782 | 622,561 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 5,782 | 5,782 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,891 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,891 | 609,131 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 2,913 | 625,474 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 2,913 | 2,915 | - | - | Performance Stock Units | |
| Kemper Corporation | Jason N. Gorevic | Director | Purchase of securities on an exchange or from another person at price $ 43.00 per share. | 03 Aug 2022 | 3,000 | 12,139 (0%) | 0% | 43 | 129,000 | Common Stock |
| Kemper Corporation | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,525 | 9,139 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 21,812 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 21,812 | 516,464 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 16,778 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 16,778 | 494,652 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 17,346 | 17,346 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 15,478 | 15,476 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 15,478 | 460,551 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 9,103 | 9,104 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 9,103 | 445,073 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 7,784 | 7,784 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 7,648 | 472,092 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 7,648 | 15,296 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 5,782 | 477,874 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 5,782 | 11,564 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 3,893 | 464,444 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 3,893 | 3,891 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 67,376 | 67,376 | - | - | Restricted Stock Units | |
| Kemper Corporation | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 614 | 6,614 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.33 per share. | 02 Nov 2021 | 5,237 | 440,733 (0%) | 0% | 150.3 | 787,257 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.40 per share. | 02 Nov 2021 | 4,763 | 435,970 (0%) | 0% | 151.4 | 721,132 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.12 per share. | 03 Aug 2021 | 10,000 | 445,970 (0%) | 0% | 150.1 | 1,501,169 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 162.47 per share. | 06 Jul 2021 | 4,283 | 460,687 (0%) | 0% | 162.5 | 695,856 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 163.39 per share. | 06 Jul 2021 | 3,267 | 457,420 (0%) | 0% | 163.4 | 533,811 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 164.22 per share. | 06 Jul 2021 | 1,350 | 456,070 (0%) | 0% | 164.2 | 221,703 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 161.27 per share. | 06 Jul 2021 | 1,000 | 464,970 (0%) | 0% | 161.3 | 161,272 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 165.15 per share. | 06 Jul 2021 | 100 | 455,970 (0%) | 0% | 165.2 | 16,515 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 153.34 per share. | 01 Jun 2021 | 10,000 | 465,970 (0%) | 0% | 153.3 | 1,533,400 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.95 per share. | 04 May 2021 | 3,853 | 477,417 (0%) | 0% | 157.0 | 604,735 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.24 per share. | 04 May 2021 | 2,400 | 481,270 (0%) | 0% | 156.2 | 374,966 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 154.12 per share. | 04 May 2021 | 1,300 | 484,670 (0%) | 0% | 154.1 | 200,354 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 158.30 per share. | 04 May 2021 | 1,047 | 476,370 (0%) | 0% | 158.3 | 165,744 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 155.06 per share. | 04 May 2021 | 1,000 | 483,670 (0%) | 0% | 155.1 | 155,055 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 159.52 per share. | 04 May 2021 | 300 | 476,070 (0%) | 0% | 159.5 | 47,857 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 160.50 per share. | 04 May 2021 | 100 | 475,970 (0%) | 0% | 160.5 | 16,050 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 182.62 per share. | 06 Apr 2021 | 10,054 | 489,860 (0%) | 0% | 182.6 | 1,836,048 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 181.55 per share. | 06 Apr 2021 | 8,056 | 499,914 (0%) | 0% | 181.5 | 1,462,547 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 183.42 per share. | 06 Apr 2021 | 3,790 | 486,070 (0%) | 0% | 183.4 | 695,160 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 180.86 per share. | 06 Apr 2021 | 3,000 | 507,970 (0%) | 0% | 180.9 | 542,566 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 184.18 per share. | 06 Apr 2021 | 100 | 485,970 (0%) | 0% | 184.2 | 18,418 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 183.18 per share. | 05 Mar 2021 | 20,220 | 548,296 (0%) | 0% | 183.2 | 3,703,980 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 8,190 | 383,649 | - | - | Employee Stock Option (right to buy) | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 05 Mar 2021 | 8,190 | 556,486 (0%) | 0% | 12.2 | 100,000 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 4,484 | 400,116 | - | - | Employee Stock Option (right to buy) | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.30 per share. | 05 Mar 2021 | 4,484 | 560,970 (0%) | 0% | 22.3 | 99,993 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 21,811 | 21,812 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 21,811 | 568,516 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 16,777 | 546,705 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 16,777 | 16,778 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 206.99 per share. | 03 Mar 2021 | 12,685 | 523,634 (0%) | 0% | 207.0 | 2,625,668 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 12,500 | 536,134 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 12,500 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 200.48 per share. | 03 Mar 2021 | 6,206 | 529,928 (0%) | 0% | 200.5 | 1,244,148 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 46,430 | 46,430 | - | - | Performance Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges